Takeda Pharmaceuticals USA, Inc. v. Allergan, Inc. et al
Takeda Pharmaceuticals USA, Inc. |
Allergan, Inc., Allergan Sales, LLC and ALLERGAN USA, INC. |
1:2019cv00534 |
January 25, 2019 |
US District Court for the Northern District of Illinois |
Jorge L Alonso |
Sheila M Finnegan |
Other Statutory Actions |
None |
Docket Report
This docket was last retrieved on March 25, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 23 MINUTE entry before the Honorable Jorge L. Alonso: Defendants' motion for leave to appear pro hac vice #22 is granted. Attorney Michael Sean Royall is given leave to file an appearance form on behalf of Defendants. Notice mailed by judge's staff (ntf, ) |
Filing 22 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15623380. (Royall, Michael) |
Filing 21 MINUTE entry before the Honorable Sheila M. Finnegan: By agreement, Takeda's combined reply in support of its Motion to Quash #1 and response to Allergan's Motion to Compel or Transfer #17 is due by 4/8/2019, and the hearing on both motions is set for 4/11/2019 at 1:30 p.m.; the hearing previously set on 4/5/2019 is cancelled.Mailed notice (sxw, ) |
Filing 20 MINUTE entry before the Honorable Jorge L. Alonso: Defendants' motions for leave to appear pro hac vice #15 and #19 are granted. Attorneys Andrew B. Blumberg and Eric Stock are given leave to file appearance forms on behalf of Defendants. The referral of this case is expanded to Magistrate Judge Finnegan to include Defendants' motion to compel or transfer #17 . Motion hearing date of 3/19/19 is stricken. Notice mailed by judge's staff (ntf, ) |
Filing 19 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15588053. (Stock, Eric) |
Filing 18 NOTICE of Motion by Andrew Benjamin Blumberg for presentment of motion to compel,, #17 before Honorable Jorge L. Alonso on 3/19/2019 at 09:30 AM. (Blumberg, Andrew) |
Filing 17 MOTION by Defendants ALLERGAN USA, INC., Allergan Sales, LLC, Allergan, Inc. to compel or Transfer (Attachments: #1 Memorandum of Law in Opposition to Takedas Motion to Quash and in Support of Allergans Motion to Compel or Transfer, #2 Declaration Declaration of in Support of Allergans Opposition to Takekdas Motion to Quash and Allergans Motion to Compel or Transfer, #3 Exhibit Shires First Amended Complaint, #4 Exhibit Allergans Memorandum of Law in Support of Defendants Motion to Dismiss, #5 Exhibit Shires First Set of Requests for the Production of Documents and Things, #6 Exhibit Stipulated Discovery Confidentiality Order)(Blumberg, Andrew) |
Filing 16 ATTORNEY Appearance for Defendants ALLERGAN USA, INC., Allergan Sales, LLC, Allergan, Inc. by Bryan D. King (King, Bryan) |
Filing 15 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15580488. (Blumberg, Andrew) |
Filing 14 MINUTE entry before the Honorable Sheila M. Finnegan: Takeda's motion to quash #1 is taken under advisement. By agreement, Allergan's response is due by 3/12/2019, and Takeda's reply by 4/2/2019. The motion hearing on 2/12/2019 is reset to 4/5/2019 at 10 a.m. Mailed notice (sxw, ) |
Filing 13 NOTICE of Motion by Morgan Reid Hirst for presentment of before Honorable Sheila M. Finnegan on 2/12/2019 at 09:15 AM. (Hirst, Morgan) |
Filing 12 EXECUTIVE COMMITTEE ORDER:Case referred to the Honorable Sheila M. Finnegan for discovery, motion #1 and settlement. Honorable Susan E. Cox no longer referred to the case. Signed by Executive Committee on 2/5/2019.(lf, ) |
Filing 11 MINUTE entry before the Honorable Susan E. Cox: Motion hearing set for 2/12/2019 at 9:30 a.m. is stricken. Mailed notice (np, ) |
Filing 10 MINUTE entry before the Honorable Susan E. Cox: Due to a personal conflict, Judge Cox recuses herself from this case. Recusal order to follow. Judge Cox no longer referred to this case. Mailed notice (np, ) |
Filing 9 NOTICE of Motion by Morgan Reid Hirst for presentment of before Honorable Susan E. Cox on 2/12/2019 at 09:30 AM. (Hirst, Morgan) |
Filing 8 EXECUTIVE COMMITTEE ORDER: Case referred to the Honorable Susan E. Cox for discovery, motion #1 and settlement. Signed by Executive Committee on 2/1/2019. (lf, ) |
Filing 7 MINUTE entry before the Honorable Jorge L. Alonso: Plaintiff's motion to quash #1 is referred to the Magistrate Judge. Motion hearing date of 2/7/19 before this Court is stricken. Notices mailed by judge's staff (ntf, ) |
Filing 6 Notice of Motion to Quash Subpoena NOTICE of Motion by Morgan Reid Hirst for presentment of before Honorable Jorge L. Alonso on 2/7/2019 at 09:30 AM. (Hirst, Morgan) |
***Civil Case Terminated. (lf, ) |
CASE ASSIGNED to the Honorable Jorge L. Alonso. Designated as Magistrate Judge the Honorable Susan E. Cox. Case assignment: Random assignment. (yt) |
Filing 5 ATTORNEY Appearance for Plaintiff Takeda Pharmaceuticals USA, Inc. by Morgan Reid Hirst (Hirst, Morgan) |
Filing 4 MEMORANDUM of Law of Takeda Pharmaceuticals USA, Inc. in Support of Its Motion to Quash (Attachments: #1 Exhibit Subpoena, #2 Exhibit Gimbert Declaration, #3 Exhibit Subpoena Response, #4 Exhibit Hirst Declaration)(Schubert, Luke) |
Filing 3 ATTORNEY Appearance for Plaintiff Takeda Pharmaceuticals USA, Inc. by Luke Holden Schubert (Schubert, Luke) |
Filing 2 CIVIL Cover Sheet (Schubert, Luke) |
Filing 1 MISCELLANEOUS CASE by All Plaintiffs Takeda Pharmaceuticals USA, Inc.'s Motion to Quash Filing fee $ 47, receipt number 0752-15417365. (Schubert, Luke) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.